雷斯托沃(GS-5806) 是新穎且有口服活性的RSV融合抑制劑，平均EC50值為0.43 nM.
(S)-tert-Butyl 2-(6-methyl-5-oxo-4,5-dihydropyrazolo[1,5-a]pyrimidin-2-yl)piperidine-1-carboxylate
(S)-1-tert-Butyl 2-methyl piperidine-1,2-dicarboxylate
(S)-tert-Butyl 2-(2-cyanoacetyl)piperidine-1-carboxylate
(S)-tert-Butyl 2-(5-amino-1H-pyrazol-3-yl)piperidine-1-carboxylate
